Alerts will be sent to your verified email
Verify EmailPOLYMED
Poly Medicure
|
TTK Healthcare
|
3B Blackbio Dx
|
|
---|---|---|---|
Operational Metrics
|
|||
Unclassified
|
|||
R&D as a % of Total Sales
|
1.32 % | 0.02 % | n/a |
Financials
|
|||
5 yr Average ROE
|
14.36 % | 21.89 % | 30.57 % |
5yr average Equity Multiplier
|
1.28 | 1.39 | 1.21 |
5yr Average Asset Turnover Ratio
|
0.64 | 0.79 | 0.5 |
5yr Avg Net Profit Margin
|
17.65 % | 24.69 % | 44.97 % |
Price to Book
|
7.15 | 1.53 | 4.46 |
P/E
|
55.32 | 25.87 | 24.41 |
5yr Avg Cash Conversion Cycle
|
48.25 Days | -18.91 Days | 128.05 Days |
Inventory Days
|
57.3 Days | 45.37 Days | 30.75 Days |
Days Receivable
|
67.43 Days | 39.11 Days | 137.66 Days |
Days Payable
|
95.26 Days | 124.35 Days | 46.71 Days |
5yr Average Interest Coverage Ratio
|
26.49 | 20.16 | 440.19 |
5yr Avg ROCE
|
18.85 % | 7.51 % | 37.21 % |
5yr Avg Operating Profit Margin
|
25.65 % | 4.27 % | 51.13 % |
5 yr average Debt to Equity
|
0.11 | 0.04 | 0.01 |
5yr CAGR Net Profit
|
20.03 % | 11.95 % | -15.98 % |
5yr Average Return on Assets
|
11.2 % | 16.71 % | 23.36 % |
Shareholdings
|
|||
Promoter Holding
|
62.44 % | 74.56 % | 41.28 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
9.1 % | 0.0 | 2.85 % |
Change in Mutual Fund Holding (3 Yrs)
|
4.42 % | -2.46 % | 0.0 |
Poly Medicure
|
TTK Healthcare
|
3B Blackbio Dx
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|